|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-4-23
|
|
pubmed:abstractText |
Platelet-derived endothelial cell growth factor (PD-ECGF) is an angiogenic factor that is expressed in various cancer tissues. Little is known regarding plasma PD-ECGF levels in patients with chronic liver disease such as chronic hepatitis (CH), cirrhosis, and hepatocellular carcinoma (HCC) with cirrhosis. The expression of PD-ECGF in HCC tissues also remains to be clarified.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1260-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9529017-Adult,
pubmed-meshheading:9529017-Aged,
pubmed-meshheading:9529017-Carcinoma, Hepatocellular,
pubmed-meshheading:9529017-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9529017-Female,
pubmed-meshheading:9529017-Humans,
pubmed-meshheading:9529017-Immunohistochemistry,
pubmed-meshheading:9529017-Liver Diseases,
pubmed-meshheading:9529017-Liver Neoplasms,
pubmed-meshheading:9529017-Male,
pubmed-meshheading:9529017-Middle Aged,
pubmed-meshheading:9529017-Thymidine Phosphorylase,
pubmed-meshheading:9529017-Tumor Markers, Biological
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
|
|
pubmed:affiliation |
Department of Clinical Research, National Shikoku Cancer Center Hospital, Ehime, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
